Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545248 | SCV000646246 | pathogenic | Charcot-Marie-Tooth disease axonal type 2C | 2024-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 620 of the TRPV4 protein (p.Val620Ile). This variant is present in population databases (rs121912633, gnomAD 0.0009%). This missense change has been observed in individual(s) with autosomal dominant brachyolmia and hereditary motor and sensory neuropathy 2 (PMID: 18587396, 20460441). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4993). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TRPV4 protein function. Experimental studies have shown that this missense change affects TRPV4 function (PMID: 18587396, 20037588, 21573172). For these reasons, this variant has been classified as Pathogenic. |
Eurofins Ntd Llc |
RCV000728663 | SCV000856265 | pathogenic | not provided | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172890 | SCV001335965 | likely pathogenic | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Clinical Genetics and Genomics, |
RCV000728663 | SCV001450405 | pathogenic | not provided | 2018-11-19 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000728663 | SCV001832462 | pathogenic | not provided | 2019-11-30 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV003992145 | SCV004812174 | likely pathogenic | Metatropic dysplasia | 2023-01-02 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000005281 | SCV000025459 | pathogenic | Brachyrachia (short spine dysplasia) | 2008-08-01 | no assertion criteria provided | literature only | |
Gene |
RCV000202535 | SCV000148033 | not provided | Skeletal dysplasia; Neuromuscular disease | no assertion provided | literature only | ||
Gene |
RCV000202464 | SCV000148034 | not provided | Skeletal dysplasia | no assertion provided | literature only |